[Local use of retabolil in the treatment of corneal pathology in experimental animals and clinical practice].
Experiments with 30 rabbits revealed enhanced corneal epithelium regeneration under the effect of local (epibulbar and subconjunctival) retabolil therapy. Clinically 15 patients with epithelial-endothelial corneal dystrophy were treated with retabolil, the treatment being effective in all the cases when the initial visual acuity was at least 0.1 diopters.
Zolotarev
A B
AB
D000287:Administration, Topical; D000368:Aged; D045930:Anabolic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D003317:Corneal Dystrophies, Hereditary / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009277:Nandrolone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077603:Nandrolone Decanoate; D011817:Rabbits; D014792:Visual Acuity
D045930:Anabolic Agents; D009277:Nandrolone; D000077603:Nandrolone Decanoate
Mestnoe primenenie retabolila pri lechenii patologii rogovitsy v éksperimente i klinike.